Editorial Commentary
Promise and pitfalls: evaluating deep learning-driven genotyping in GISTs
Gastrointestinal Stromal Tumor
2025;
8:
6
.
(30 September 2025)
Editorial Commentary
Additive value of inflammatory markers in predicting outcomes in resectable gastrointestinal stromal tumor patients
Gastrointestinal Stromal Tumor
2025;
8:
5
.
(30 September 2025)
Editorial Commentary
RECKGIST is an appropriate relapse risk scoring system for gastrointestinal stromal tumors in patients with neurofibromatosis
Gastrointestinal Stromal Tumor
2025;
8:
4
.
(30 September 2025)
